|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUE | |||||
| License revenue | |||||
| License and other revenue | |||||
| Collaboration revenue | |||||
| Other revenue | |||||
| Total revenue | |||||
| Other income and gains | |||||
| Cost of collaboration revenue | |||||
| Cost of license and other revenue | |||||
| Research and development expenses | |||||
| Administrative expenses | |||||
| Selling and distribution expenses | |||||
| Other income and gains | |||||
| Other expenses | |||||
| Fair value (loss)/gain of warrant liability | |||||
| Loss on asset impairment | |||||
| Other operating expense | |||||
| Operating loss | |||||
| Finance costs | |||||
| Finance income | |||||
| Other (expense)/ income, net | |||||
| Loss before tax | |||||
| Income tax (expense)/benefit | |||||
| Net loss | |||||
| Ordinary equity holders of the parent | |||||
| LOSS PER SHARE | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| OTHER COMPREHENSIVE (LOSS) INCOME | |||||
| Other comprehensive income that may be reclassified to profit or loss in subsequent periods: | |||||
| Exchange differences on translation of foreign operations | |||||
| Net other comprehensive (loss) income | |||||
| Other comprehensive income/(loss), net of tax | |||||
| TOTAL COMPREHENSIVE LOSS | |||||
Loading...